Catriona Yale, Chief Development Officer: Akero Therapeutics AKRO Sell · Filed 25/02/21

Trade details

Type: Insider sale
Amount: $453,089
Shares · price: 9,100 sh · $49.79 a share
Held after: 96,548 sh
Stock: Akero Therapeutics AKRO
Person: Catriona YaleChief Development Officer
Trade date: 25/02/18
Filed: 25/02/21
Days to filing: 3 days

Sold 8.6% of holdings

Share of holding sold: 8.6%

Akero Therapeutics trades, last 26 weeks

What else happened in Akero Therapeutics around then

Filed or reported within 30 days of the trade day · 25/01/19~25/03/20

Catriona Yale's recent trades

Catriona YaleChief Development Officer
SellAkero Therapeutics
Sell
Akero Therapeutics
AKRO
$28.4K
659 sh
$28.4K
Filed 25/09/12
Traded 25/09/11
Catriona YaleChief Development Officer
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$457.7K
8,658 sh
$457.7K
Filed 25/07/18
Traded 25/07/16
Catriona YaleChief Development Officer
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$71.8K
1,342 sh
$71.8K
Filed 25/07/18
Traded 25/07/16
Catriona YaleChief Development Officer
SellAkero Therapeutics
Sell
Akero Therapeutics
AKRO
$89.6K
1,633 sh
$89.6K
Filed 25/06/20
Traded 25/06/18
Catriona YaleChief Development Officer
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$334K
6,210 sh
$334K
Filed 25/06/20
Traded 25/06/16

Catriona Yale, Chief Officer — sold $453.1K of Akero Therapeutics AKRO · 8.6% of holdings · 10b5-1 plan | Whalegun